Athersys Plans to Begin First Stroke Clinical Study by End of Year

Athersys will begin the first clinical study of its MultiStem stem cell therapy in stroke patients before the end of the year. The study involves approximately 150 individuals and is being followed by the ALS community because of the therapy’s potential relevance in ALS.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail